These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25420699)

  • 1. Enhanced surveillance of hepatitis C in the EU, 2006 - 2012.
    Duffell EF; van de Laar MJ; Amato-Gauci AJ
    J Viral Hepat; 2015 Jul; 22(7):590-5. PubMed ID: 25420699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced surveillance of hepatitis B in the EU, 2006-2012.
    Duffell EF; van de Laar MJ; Amato-Gauci AJ
    J Viral Hepat; 2015 Jul; 22(7):581-9. PubMed ID: 25417854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.
    Hollo V; Kotila SM; Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where next for hepatitis B and C surveillance?
    Wiktor SZ
    J Viral Hepat; 2015 Jul; 22(7):571-3. PubMed ID: 25754464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between males and females in infectious diseases notifications in the EU/EEA, 2012 to 2021.
    Beauté J; Innocenti F
    Euro Surveill; 2024 Aug; 29(33):. PubMed ID: 39149823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.
    Leitmeyer KC; Espinosa L; Broberg EK; Struelens MJ; ;
    Euro Surveill; 2020 Oct; 25(39):. PubMed ID: 33006301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A notifications in the EU/EEA, 2010-2019: what can we learn from case reporting to the European Surveillance System?
    Severi E; Tavoschi L; Carrillo-Santisteve P; Westrell T; Marrone G; Giesecke J; Lopalco P
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.
    Navarro Torné A; Dias JG; Quinten C; Hruba F; Busana MC; Lopalco PL; Gauci AJ; Pastore-Celentano L;
    Vaccine; 2014 Jun; 32(29):3644-50. PubMed ID: 24795228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of congenital rubella and rubella infections in pregnancy in EU/EEA countries, 2012: Current status and future perspective to monitor elimination.
    Giambi C; Montaño-Remacha C; Celentano LP; Derrough T;
    Vaccine; 2015 Sep; 33(38):4929-37. PubMed ID: 26209837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C in Poland in 2010].
    Rosińska M; Radziszewski F; Stepień M
    Przegl Epidemiol; 2012; 66(2):287-92. PubMed ID: 23101218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in Poland in 2013.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2015; 69(2):277-82, 389-93. PubMed ID: 26233087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in China: an emerging public health issue.
    Qin Q; Smith MK; Wang L; Su Y; Wang L; Guo W; Wang L; Cui Y; Wang N
    J Viral Hepat; 2015 Mar; 22(3):238-44. PubMed ID: 25131856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C enhanced surveillance: results from a southeastern Sydney pilot program.
    Bateman-Steel CR; Smedley EJ; Kong M; Ferson MJ
    Public Health Res Pract; 2015 Mar; 25(2):e2521520. PubMed ID: 25848738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009.
    Duffell EF; van de Laar MJ
    Euro Surveill; 2015 Apr; 20(13):17-24. PubMed ID: 25860392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009.
    Sandgren A; Hollo V; Quinten C; Manissero D
    Euro Surveill; 2011 Mar; 16(12):. PubMed ID: 21457686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.